Mpm Asset Management LLC
10% owner at Aktis Oncology; Insider at Werewolf Therapeutics.
- Rank
- 532nd of 813
- Companies held
- 2
- Largest holding
- AKTS, 95.7% of total
- Latest SEC filing
- Jan 12, 2026
- Listed but not counted
- $31.9M
What the $153M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Aktis Oncology AKTS Common Stock | Indirectly (see filing footnote) Reported jointly by 2 insiders; split evenly | 5,130,032 | $16.40 | $84.1M | 55.0% | Form 4, Jan 12, 2026 |
| Aktis Oncology AKTS Common Stock | Indirectly (see filing footnote) Reported jointly by 2 insiders; split evenly | 3,785,084 | $16.40 | $62.1M | 40.6% | Form 4, Jan 12, 2026 |
| Werewolf Therapeutics HOWL Common Stock | Through AM LLC | 6,718,670 | $0.99 | $6.6M | 4.3% | Form 4, Mar 27, 2025 |
Share counts are the amounts Mpm Asset Management LLC reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Mpm Asset Management LLC's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Aktis Oncology AKTS Common Stock | Through MPM Asset Management LLC Held by an investment fund or partnership | 1,655,971 | $16.40 | $27.2M | — | Form 4, Jan 12, 2026 |
| Werewolf Therapeutics HOWL Common Stock | Through AM LLC Held by a company or fund the insider manages | 4,784,111 | $0.99 | $4.7M | — | Form 4, Dec 4, 2025 |
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 529 | Yorktown Energy Partners IX, L.P. 10% owner, Riley Exploration Permian | $154M |
| 530 | Third Rock Ventures V, L.P. Director, Rapport Therapeutics | $154M |
| 531 | New Enterprise Associates 14, L.P. 10% owner, Enliven Therapeutics | $153M |
| 532 | Mpm Asset Management LLC 10% owner, Aktis Oncology | $153M |
| 533 | RC IV Cayman ICW Equity LLC Insider, Driven Brands Holdings | $152M |
| 534 | Honeywell International INC 10% owner, Quantinuum | $152M |
| 535 | Casdin Partners FO1-MSV, LP 10% owner, GeneDx Holdings | $152M |
Other Aktis Oncology insiders
All AKTS insiders- Todd Foley$123MDirector. #1291 overall
Questions
How much stock does Mpm Asset Management LLC own?
Mpm Asset Management LLC holds $152,832,511 in listed stock based on SEC filings and current prices, mostly Aktis Oncology (AKTS). That ranks 532nd on the Stock Rich List.
Is this Mpm Asset Management LLC's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Mpm Asset Management LLC last buy or sell stock?
The most recent open-market trade on file is a purchase of 1,112,777 AKTS shares on Jan 12, 2026 at $18.00.
Files jointly with Ansbert Gadicke.